PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2569837-1	1989	Previous reports of somatostatin"s atropine-sensitive negative inotropic effect on cardiac function prompted the present studies to characterize the molecular forms and actions of somatostatin in the canine heart.	Atropine	35-43	somatostatin	Canis lupus familiaris	20-32	
1980784-6	1990	The antagonistic effect of somatostatin on the spontaneous and motilin-induced contractions resembled the effect of atropine and probably resulted from the decreased acetylcholine release in the cholinergic neurons.	Atropine	116-124	somatostatin	Canis lupus familiaris	27-39	
6127867-1	1982	Initial atropine resistant vagally mediated decrease of somatostatin levels and increase of gastrin and insulin levels.	Atropine	8-16	somatostatin	Canis lupus familiaris	56-68	
2892879-0	1987	The effects of the antimuscarinic drugs pirenzepine and atropine on plasma portal levels of somatostatin and gastrin in the dog.	Atropine	56-64	somatostatin	Canis lupus familiaris	92-104	
2892879-1	1987	The effects of the antimuscarinic drugs pirenzepine and atropine on somatostatin and gastrin portal levels under basal conditions and during bethanechol infusion have been investigated in anesthetized dogs.	Atropine	56-64	somatostatin	Canis lupus familiaris	68-80	
6127867-11	1982	The process of feeding induces an atropine resistant, vagally mediated decrease in somatostatin release from the gastrointestinal tract and this decreased output of somatostatin facilitates initiation of meal-related endocrine and exocrine gastric secretions.	Atropine	34-42	somatostatin	Canis lupus familiaris	83-95